TPO and hematocrit: Anti-TPO Abs were detected in 80% of MAP/PI-positive patients and revealed a moderate correlation with concentrations of anti-MAP Abs; a high prevalence of Abs against the homologous peptides among anti-TPO-negative HT subjects requires evaluation in a wider number of patients.